{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:50:35Z","timestamp":1790653835333,"version":"4.1.0"},"reference-count":103,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation, Republic of Korea","award":["NRF-2018R1C1B6008282"],"award-info":[{"award-number":["NRF-2018R1C1B6008282"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Transthyretin (TTR) is an essential transporter of a thyroid hormone and a holo-retinol binding protein, found abundantly in human plasma and cerebrospinal fluid. In addition, this protein is infamous for its amyloidogenic propensity, causing various amyloidoses in humans, such as senile systemic amyloidosis, familial amyloid polyneuropathy, and familial amyloid cardiomyopathy. It has been known for over two decades that decreased stability of the native tetrameric conformation of TTR is the main cause of these diseases. Yet, mechanistic details on the amyloidogenic transformation of TTR were not clear until recent multidisciplinary investigations on various structural states of TTR. In this review, we discuss recent advancements in the structural understanding of TTR misfolding and amyloidosis processes. Special emphasis has been laid on the observations of novel structural features in various amyloidogenic species of TTR. In addition, proteolysis-induced fragmentation of TTR, a recently proposed mechanism facilitating TTR amyloidosis, has been discussed in light of its structural consequences and relevance to acknowledge the amyloidogenicity of TTR.<\/jats:p>","DOI":"10.3390\/ijms22094429","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T12:08:30Z","timestamp":1619179710000},"page":"4429","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism"],"prefix":"10.3390","volume":"22","author":[{"given":"Jin-Beom","family":"Si","sequence":"first","affiliation":[{"name":"Department of New Biology, Daegu Gyeongbuk Institute of Science &amp; Technology (DGIST), Daegu 42988, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokyung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of New Biology, Daegu Gyeongbuk Institute of Science &amp; Technology (DGIST), Daegu 42988, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6776-2451","authenticated-orcid":false,"given":"Jin Hae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of New Biology, Daegu Gyeongbuk Institute of Science &amp; Technology (DGIST), Daegu 42988, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/endo-63-2-256","article-title":"Pre-albumin: A thyroxine-binding protein of human plasma","volume":"63","author":"Ingbar","year":"1958","journal-title":"Endocrinology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1152\/physrev.1960.40.3.415","article-title":"Proteins associated with the thyroid hormones","volume":"40","author":"Robbins","year":"1960","journal-title":"Physiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI104701","article-title":"Observations concerning the binding of thyroid hormones by human serum prealbumin","volume":"42","author":"Ingbar","year":"1963","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0009-8981(68)90173-3","article-title":"Influence of age and sex on prealbumin levels","volume":"20","author":"Stabilini","year":"1968","journal-title":"Clin. Chim. Acta"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"R338","DOI":"10.1152\/ajpregu.1990.258.2.R338","article-title":"Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus","volume":"258","author":"Schreiber","year":"1990","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1515\/CCLM.2002.223","article-title":"Transthyretin as a thyroid hormone carrier: Function revisited","volume":"40","author":"Palha","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1073\/pnas.82.8.2488","article-title":"Plasma and cellular retinoid-binding proteins and transthyretin (prealbumin) are all localized in the islets of Langerhans in the rat","volume":"82","author":"Kato","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","first-page":"23","article-title":"Expression of transthyretin and retinol binding protein mRNAs and secretion of transthyretin by cultured monkey retinal pigment epithelium","volume":"10","author":"Pfeffer","year":"2004","journal-title":"Mol. Vis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0022-2836(71)90218-X","article-title":"An X-ray study of the subunit structure of prealbumin","volume":"61","author":"Blake","year":"1971","journal-title":"J. Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0022-2836(78)90368-6","article-title":"Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 \u00c5","volume":"121","author":"Blake","year":"1978","journal-title":"J. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1107\/S0907444996003046","article-title":"Structures of human transthyretin complexed with thyroxine at 2.0 \u00c5 resolution and 3\u2032,5\u2032-dinitro-N-acetyl-L-thyronine at 2.2 \u00c5 resolution","volume":"52","author":"Wojtczak","year":"1996","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1073\/pnas.75.9.4499","article-title":"Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy","volume":"75","author":"Costa","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","article-title":"Fibril in senile systemic amyloidosis is derived from normal transthyretin","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00019052-199610000-00007","article-title":"Familial amyloid polyneuropathy: New developments in genetics and treatment","volume":"9","author":"Coelho","year":"1996","journal-title":"Curr. Opin. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human transthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African\u2013Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2016.200","article-title":"Transthyretin V122I (pV142I)* cardiac amyloidosis: An age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans","volume":"19","author":"Buxbaum","year":"2017","journal-title":"Genet. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/13506129.2020.1764928","article-title":"DISCOVERY: Prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis","volume":"27","author":"Akinboboye","year":"2020","journal-title":"Amyloid"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The transthyretin amyloidoses: From delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug","volume":"421","author":"Johnson","year":"2012","journal-title":"J. Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1021\/bi00151a036","article-title":"Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro","volume":"31","author":"Colon","year":"1992","journal-title":"Biochemistry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"Inhibiting transthyretin amyloid fibril formation via protein stabilization","volume":"93","author":"Miroy","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/anie.200351179","article-title":"Benzoxazoles as transthyretin amyloid fibril inhibitors: Synthesis, evaluation, and mechanism of action","volume":"42","author":"Razavi","year":"2003","journal-title":"Angew. Chemie Int. Ed."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/ar020073i","article-title":"Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses","volume":"38","author":"Johnson","year":"2005","journal-title":"Acc. Chem. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41569-018-0089-6","article-title":"Tafamidis: A new treatment for ATTR cardiomyopathy","volume":"15","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2147\/DDDT.S289772","article-title":"Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story","volume":"15","author":"Burton","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1006\/jmbi.2000.4078","article-title":"A comparative analysis of 23 structures of the amyloidogenic protein transthyretin","volume":"302","author":"Eneqvist","year":"2000","journal-title":"J. Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2174\/092986712800269335","article-title":"Nearly 200 X-ray crystal structures of transthyretin: What do they tell us about this protein and the design of drugs for TTR amyloidoses?","volume":"19","author":"Palaninathan","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zanotti, G., Vallese, F., Ferrari, A., Menozzi, I., Salda\u00f1o, T.E., Berto, P., Fernandez-Alberti, S., and Berni, R. (2017). Structural and dynamics evidence for scaffold asymmetric flexibility of the human transthyretin tetramer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187716"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.1021\/bi051608t","article-title":"The pathway by which the tetrameric protein transthyretin dissociates","volume":"44","author":"Foss","year":"2005","journal-title":"Biochemistry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1073\/pnas.1317488111","article-title":"Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis","volume":"111","author":"Mangione","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1002\/anie.201608516","article-title":"Structure of monomeric transthyretin carrying the clinically important T119M mutation","volume":"55","author":"Kim","year":"2016","journal-title":"Angew. Chemie Int. Ed."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nsmb.3380","article-title":"Mechanistic basis for the recognition of a misfolded protein by the molecular chaperone Hsp90","volume":"24","author":"Oroz","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11442","DOI":"10.1021\/bi011194d","article-title":"An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured","volume":"40","author":"Jiang","year":"2001","journal-title":"Biochemistry"},{"key":"ref_37","first-page":"179","article-title":"A strikingly benign evolution of FAP in an individual found to be a compound heterozygote for two TTR mutations: TTR Met30 and TTR Met119","volume":"20","author":"Coelho","year":"1993","journal-title":"J. Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1126\/science.1062245","article-title":"Trans-suppression of misfolding in an amyloid disease","volume":"293","author":"Schneider","year":"2001","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jmb.2013.01.008","article-title":"Localized structural fluctuations promote amyloidogenic conformations in transthyretin","volume":"425","author":"Lim","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pnmrs.2017.05.003","article-title":"Monitoring protein folding through high pressure NMR spectroscopy","volume":"102\u2013103","author":"Roche","year":"2017","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1073\/pnas.97.12.6445","article-title":"The preaggregated state of an amyloidogenic protein: Hydrostatic pressure converts native transthyretin into the amyloidogenic state","volume":"97","author":"Souto","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.1734009100","article-title":"Dissociation of amyloid fibrils of \u03b1-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities","volume":"100","author":"Foguel","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1074\/jbc.M807100200","article-title":"Trapping the monomer of a non-amyloidogenic variant of transthyretin: Exploring its possible use as a therapeutic strategy against transthyretin amyloidogenic diseases","volume":"284","author":"Palhano","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0006-291X(91)91687-8","article-title":"Normal transthyretin and synthetic transthyretin fragments from amyloid-like fibrils in vitro","volume":"175","author":"Gustavsson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1021\/bi3002727","article-title":"Specific disruption of transthyretin(105-115) fibrilization using \u201cstabilizing\u201d inhibitors of transthyretin amyloidogenesis","volume":"51","author":"Liang","year":"2012","journal-title":"Biochemistry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1073\/pnas.1219476110","article-title":"Atomic structure and hierarchical assembly of a cross-\u03b2 amyloid fibril","volume":"110","author":"Fitzpatrick","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"12781","DOI":"10.1002\/anie.201407323","article-title":"Conformational flexibility tunes the propensity of transthyretin to form fibrils through non-native intermediate states","volume":"53","author":"Das","year":"2014","journal-title":"Angew. Chemie Int. Ed."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/acs.biochem.6b00164","article-title":"Structural changes associated with transthyretin misfolding and amyloid formation revealed by solution and solid-state NMR","volume":"55","author":"Lim","year":"2016","journal-title":"Biochemistry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10988","DOI":"10.1038\/s41598-019-47230-4","article-title":"Probing conformational changes of monomeric transthyretin with second derivative fluorescence","volume":"9","author":"Jazaj","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.bpj.2020.08.043","article-title":"Edge strand dissociation and conformational changes in transthyretin under amyloidogenic conditions","volume":"119","author":"Childers","year":"2020","journal-title":"Biophys. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"28932","DOI":"10.1074\/jbc.M115.659912","article-title":"Uncovering the mechanism of aggregation of human transthyretin","volume":"290","author":"Saelices","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsb.2011.12.022","article-title":"Hydrogen-bond network and pH sensitivity in transthyretin: Neutron crystal structure of human transthyretin","volume":"177","author":"Yokoyama","year":"2012","journal-title":"J. Struct. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/1873-3468.12704","article-title":"Stability and crystal structures of His88 mutant human transthyretins","volume":"591","author":"Yokoyama","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/acs.biochem.7b00815","article-title":"Fluorotryptophan incorporation modulates the structure and stability of transthyretin in a site-specific manner","volume":"56","author":"Sun","year":"2017","journal-title":"Biochemistry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/ar0500719","article-title":"\u03b1-sheet: The toxic conformer in amyloid diseases?","volume":"39","author":"Daggett","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"ref_56","first-page":"247","article-title":"The role of \u03b1-sheet in amyloid oligomer aggregation and toxicity","volume":"91","author":"Bi","year":"2018","journal-title":"Yale J. Biol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.str.2004.08.005","article-title":"Anatomy of an amyloidogenic intermediate: Conversion of \u03b2-sheet to \u03b1-sheet structure in transthyretin at acidic pH","volume":"12","author":"Armen","year":"2004","journal-title":"Structure"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/protein\/gzm086","article-title":"Different disease-causing mutations in transthyretin trigger the same conformational conversion","volume":"21","author":"Steward","year":"2008","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1021\/acs.biochem.9b00769","article-title":"Drivers of \u03b1-sheet formation in transthyretin under amyloidogenic conditions","volume":"58","author":"Childers","year":"2019","journal-title":"Biochemistry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e01681","DOI":"10.7554\/eLife.01681","article-title":"Designed \u03b1-sheet peptides inhibit amyloid formation by targeting toxic oligomers","volume":"3","author":"Hopping","year":"2014","journal-title":"Elife"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1021\/acs.biochem.7b00345","article-title":"Chemical and physical variability in structural isomers of an L\/D \u03b1-sheet peptide designed to inhibit amyloidogenesis","volume":"57","author":"Maris","year":"2018","journal-title":"Biochemistry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1021\/bi048838c","article-title":"Dimeric transthyretin variant assembles into spherical neurotoxins","volume":"44","author":"Matsubara","year":"2005","journal-title":"Biochemistry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/13506129.2012.666510","article-title":"Quaternary structure, aggregation and cytotoxicity of transthyretin","volume":"19","author":"Mizuguchi","year":"2012","journal-title":"Amyloid"},{"key":"ref_64","first-page":"1","article-title":"Dynamics and thermodynamics of transthyretin association from molecular dynamics simulations","volume":"7480749","author":"Corazza","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acs.analchem.8b05066","article-title":"Topological analysis of transthyretin disassembly mechanism: Surface-induced dissociation reveals hidden reaction pathways","volume":"91","author":"Shirzadeh","year":"2019","journal-title":"Anal. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"39592","DOI":"10.1074\/jbc.M103599200","article-title":"Capture of a dimeric intermediate during transthyretin amyloid formation","volume":"276","author":"Olofsson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41598-018-37230-1","article-title":"Transthyretin aggregation pathway toward the formation of distinct cytotoxic oligomers","volume":"9","author":"Dasari","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e2587","DOI":"10.1002\/jmr.2587","article-title":"Force spectroscopy reveals the presence of structurally modified dimers in transthyretin amyloid annular oligomers","volume":"30","author":"Pires","year":"2017","journal-title":"J. Mol. Recognit."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: Evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Cardoso","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"Reixach","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1039\/C4CP04549A","article-title":"A look into amyloid formation by transthyretin: Aggregation pathway and a novel kinetic model","volume":"17","author":"Faria","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Pires, R.H., Karsai, \u00c1., Saraiva, M.J., Damas, A.M., and Kellermayer, M.S.Z. (2012). Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044992"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jmr.1112","article-title":"Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy","volume":"24","author":"Pires","year":"2011","journal-title":"J. Mol. Recognit."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Frangolho, A., Correia, B.E., Vaz, D.C., Almeida, Z.L., and Brito, R.M.M. (2020). Oligomerization profile of human transthyretin variants with distinct amyloidogenicity. Molecules, 25.","DOI":"10.3390\/molecules25235698"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1021\/acs.biochem.6b00649","article-title":"Solid-state NMR studies reveal native-like \u03b2-sheet structures in transthyretin amyloid","volume":"55","author":"Lim","year":"2016","journal-title":"Biochemistry"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1021\/acs.biochem.7b00658","article-title":"Pathogenic mutations induce partial structural changes in the native \u03b2-sheet structure of transthyretin and accelerate aggregation","volume":"56","author":"Lim","year":"2017","journal-title":"Biochemistry"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1073\/pnas.0304849101","article-title":"High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy","volume":"101","author":"Jaroniec","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/j.1460-2075.1993.tb05708.x","article-title":"Modifications of transthyretin in amyloid fibrils: Analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation","volume":"12","author":"Thylen","year":"1993","journal-title":"EMBO J."},{"key":"ref_80","first-page":"772","article-title":"Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy","volume":"227","author":"Hermansen","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.1759","article-title":"Amyloid deposits in transthyretin-derived amyloidosis: Cleaved transthyretin is associated with distinct amyloid morphology","volume":"206","author":"Gustavsson","year":"2005","journal-title":"J. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1021\/ac061546s","article-title":"Detailed structural analysis of amyloidogenic wild-type transthyretin using a novel purification strategy and mass spectrometry","volume":"79","author":"Kingsbury","year":"2007","journal-title":"Anal. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-019-08609-z","article-title":"A molecular mechanism for transthyretin amyloidogenesis","volume":"10","author":"Yee","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15252\/emmm.201505357","article-title":"A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis","volume":"7","author":"Marcoux","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"E6428","DOI":"10.1073\/pnas.1802977115","article-title":"Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease","volume":"115","author":"Klimtchuk","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/acs.biochem.0c00079","article-title":"Disruption of the CD loop by enzymatic cleavage promotes the formation of toxic transthyretin oligomers through a common transthyretin misfolding pathway","volume":"59","author":"Dasari","year":"2020","journal-title":"Biochemistry"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s42003-020-01493-0","article-title":"A serine protease secreted from Bacillus subtilis cleaves human plasma transthyretin to generate an amyloidogenic fragment","volume":"3","author":"Peterle","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.RA118.003990","article-title":"Plasminogen activation triggers transthyretin amyloidogenesis in vitro","volume":"293","author":"Mangione","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"20483","DOI":"10.1073\/pnas.1008255107","article-title":"Trapping of palindromic ligands within native transthyretin prevents amyloid formation","volume":"107","author":"Kolstoe","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1021\/acs.jmedchem.9b01037","article-title":"Binding of monovalent and bivalent ligands by transthyretin causes different short- and long-distance conformational changes","volume":"62","author":"Corazza","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/bi00673a014","article-title":"Negative cooperativity in the binding of thyroxine to human serum prealbumin","volume":"14","author":"Ferguson","year":"1975","journal-title":"Biochemistry"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"29769","DOI":"10.1074\/jbc.M115.690172","article-title":"Transthyretin binding heterogeneity and antiamyloidogenic activity of natural polyphenols and their metabolites","volume":"290","author":"Florio","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-2836(02)00471-0","article-title":"Native state hydrogen exchange study of suppressor and pathogenic variants of transthyretin","volume":"320","author":"Liu","year":"2002","journal-title":"J. Mol. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/acn3.50887","article-title":"Biophysical characterization and modulation of Transthyretin Ala97Ser","volume":"6","author":"Liu","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"592644","DOI":"10.3389\/fnmol.2020.592644","article-title":"Modulation of the mechanisms driving transthyretin amyloidosis","volume":"13","author":"Bezerra","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/acs.biochem.8b00642","article-title":"NMR measurements reveal the structural basis of transthyretin destabilization by pathogenic mutations","volume":"57","author":"Leach","year":"2018","journal-title":"Biochemistry"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"E6201","DOI":"10.1073\/pnas.1807024115","article-title":"Kinetic analysis of the multistep aggregation pathway of human transthyretin","volume":"115","author":"Sun","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"E6741","DOI":"10.1073\/pnas.1805131115","article-title":"Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition","volume":"115","author":"Saelices","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.1038\/srep11443","article-title":"Considerably unfolded transthyretin monomers preceed and exchange with dynamically structured amyloid protofibrils","volume":"5","author":"Groenning","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1021\/bi1004409","article-title":"The Crystal Structure of the Green Tea Polyphenol (\u2212)-Epigallocatechin Gallate\u2212Transthyretin Complex Reveals a Novel Binding Site Distinct from the Thyroxine Binding Site","volume":"49","author":"Miyata","year":"2010","journal-title":"Biochemistry"},{"key":"ref_101","first-page":"123","article-title":"Transthyretin chemical chaperoning by flavonoids: Structure-activity insights towards the design of potent amyloidosis inhibitors","volume":"3","author":"Ferreira","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/cmdc.201600092","article-title":"Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds","volume":"11","author":"Ortore","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants","volume":"276","author":"Quintas","year":"2001","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4429\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:51:58Z","timestamp":1760161918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":103,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22094429"],"URL":"https:\/\/doi.org\/10.3390\/ijms22094429","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]}}}